Mercury Laboratories Ltd.

View in App
782.00 -0.80 ▼-0.1%

05 December 2023, 04:01:00 PM
Volume: 3

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.mercurylabs.com
Market Cap 93.84 Cr.
Enterprise Value(EV) 93.63 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 29.01 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 26.96 Trailing Twelve Months Ending 2023-09
Industry PE 38.71 Trailing Twelve Months Ending 2023-09
Book Value / Share 397.48 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.97 Calculated using Price: 782.00
Dividend Yield 0.45 Period Ending 2023-03
No. of Shares Subscribed 0.12 Cr. 1,200,000 Shares
FaceValue 10
About Mercury Laboratories Ltd.
The company is engaged in manufacturing of pharmaceutical products. It is mainly dedicated to Mother and child care products.

Mercury Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Mercury Laboratories Ltd. Performance

View details >>
1 Day
-0.10%
1 Week
-2.55%
1 Month
-1.64%
3 Month
-3.46%
6 Month
+1.64%
1 Year
-5.21%
2 Year
+35.35%
5 Year
+97.97%
10 Year

Mercury Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 19.75 19.62 11.67 7.92 10.26 10.59 15.50 9.23 12.98
Return on Capital Employed (%) 21.32 21.58 18.93 9.89 13.77 13.25 20.56 12.26 16.29
Return on Assets (%) 8.01 8.81 5.54 3.92 5.20 5.68 8.77 5.57 8.58

Mercury Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 18 22 24 26 29 32 37 40 46 48
Non Curr. Liab. 4 4 10 12 11 9 10 6 6 6
Curr. Liab. 21 20 17 13 17 15 19 16 16 21
Minority Int.
Equity & Liab. 43 47 51 52 57 56 65 62 68 75
Non Curr. Assets 20 19 20 22 25 25 28 27 26 27
Curr. Assets 23 28 31 30 32 32 38 35 42 48
Misc. Exp. not W/O
Total Assets 43 47 51 52 57 56 65 62 68 75

Mercury Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 41 48 48 52 56 57 69 58 75 77
Other Income 1 1 0 0 1 1 1 1 2 2
Total Income 42 48 48 52 57 58 69 59 77 78
Total Expenditure -35 -41 -41 -47 -50 -51 -59 -51 -67 -71
PBIDT 7 7 7 5 7 7 10 8 10 7
Interest -1 -1 -1 -1 -1 -1 -1 0 0 0
Depreciation -1 -1 -1 -1 -2 -2 -2 -2 -2 -3
Taxation -1 -1 -2 0 -1 -1 -3 -1 -2 -1
Exceptional Items 0 0 0
PAT 3 4 3 2 3 3 5 4 6 3
Adjusted EPS 28 33 23 17 24 27 44 30 46 29

Mercury Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 3 3 0 2 5 5 5 8 5 2
Cash Fr. Inv. -2 -2 0 -2 -4 -5 -1 -5 -2 -1
Cash Fr. Finan. -1 -2 0 0 1 -3 -3 -1 -1 -1
Net Change 0 0 0 0 2 -2 1 2 2 0
Cash & Cash Eqvt 1 1 1 1 4 1 3 5 7 7

Mercury Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 73.66 73.66 73.66 73.66 73.66 73.66 73.66 73.66 73.66
Public 26.34 26.34 26.34 26.34 26.34 26.34 26.34 26.34 26.34
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Mercury Laboratories Ltd. Announcements

View details >>
Fri, 10 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of unaudited financial statement as on September 30 2023 under regulation 47 of SEBI(LODR)
Wed, 08 Nov 2023
Results_Unaudited Financial Statement As On Sep-23
Results_unaudited Financial Statement as on sep-23
Wed, 08 Nov 2023
Announcement under Regulation 30 (LODR)-Change in Management
Disclosure under Reg 30 of SEBI(LODR) Reg 2015-Appointmnet of senior management

Mercury Laboratories Ltd. Technical Scans

View details >>
Tue, 05 Dec 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Opening at Low Opening at Low
Closing Near 20 SMA Closing Near 20 SMA
William %R Trending Down William %R Trending Down

Mercury Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,541.53 1,240.10 +0.7%
Divi's Laboratories Ltd. 99,355.60 3,744.50 -1.4%
Cipla Ltd. 98,827.76 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. 96,346.31 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. 80,129.03 5,569.05 -1.0%
Mankind Pharma Ltd. 78,038.63 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. 71,060.00 2,101.30 -1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.81 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-09 74.60 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-09 28.62 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.92 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.88 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 60.88 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.27 2,101.30 -1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-09 7.84 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-09 3.98 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.78 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.33 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 9.26 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.59 2,101.30 -1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,101.30 -1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,101.30 -1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,101.30 -1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,101.30 -1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,240.10 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,744.50 -1.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,224.10 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,777.65 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,569.05 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,948.50 +1.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,101.30 -1.4%

Mercury Laboratories Ltd. FAQ's

What is Mercury Laboratories share price?
Can I buy Mercury Laboratories shares now?
What is the Dividend Yield of Mercury Laboratories?
What is the Market Cap of Mercury Laboratories?
What are the key metrics to analyse Mercury Laboratories?
What is the 52 Week High and Low of Mercury Laboratories?
What is the trend of Mercury Laboratories share price?